Generics Players Dominating New OTC Launches In Germany
An analysis by Sempora Consulting of the German OTC market in 2018 shows that generic products dominate new OTC product launches.
You may also be interested in...
Novartis has no plans to sell Sandoz, nor to move the generics division’s headquarters from its current location in Holzkirchen, Germany. Legacy German brand Hexal also remains part of the company’s plans.
A mild cold season contributed to a decline in Germany's OTC market turnover in the first quarter 2019 compared with the previous year, according to data from IQVIA.
A prescription-to-OTC switch for levocetirizine has opened the door for generic producers such as Sandoz’ Hexal to extend their consumer healthcare allergy offerings in Germany.